Correction to: NEAR trial: A single-arm phase II trial of neoadjuvant apalutamide monotherapy and radical prostatectomy in intermediate- and high-risk prostate cancer

Prostate Cancer Prostatic Dis. 2022 Apr;25(4):803. doi: 10.1038/s41391-022-00522-9.

Lui Shiong Lee^#^{1

2}, Adelene Y L Sim^#^{3

4}, Chee Wee Ong^#⁵, Xinyan Yang^#⁵, Cedric C Y Ng⁴, Wei Liu⁴, Vikneswari Rajasegaran⁴, Abner M S Lim⁴, Edwin Jonathan Aslim⁵, Nye-Thane Ngo^{3

6}, Li-Yan Khor^{3

6}, Ravindran Kanesvaran^{3

7}, John Carson Jr Allen⁸, Kae Jack Tay^{3

5}, John Shyi Peng Yuen^{3

5}, Tsung Wen Chong^{3

5}, Sun Sien Henry Ho^{3

5}, Bin Tean Teh^{3

4}, Melvin L K Chua^{3

4

9}

¹ Department of Urology, Sengkang General Hospital, Singapore, Singapore. [email protected].
² Duke-NUS Medical School, Singapore, Singapore. [email protected].
³ Duke-NUS Medical School, Singapore, Singapore.
⁴ Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Singapore.
⁵ Department of Urology, Singapore General Hospital, Singapore, Singapore.
⁶ Department of Anatomic Pathology, Singapore General Hospital, Singapore, Singapore.
⁷ Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
⁸ Center for Quantitative Medicine/Office of Research, Duke-NUS Medical School, Singapore, Singapore.
⁹ Division of Radiation Oncology, National Cancer Centre Singapore, Singapore, Singapore.

^# Contributed equally.

No abstract available

Publication types